期刊文献+

儿童髓母细胞瘤术后的生存情况及其影响因素分析 被引量:2

Postoperative survival of children with medulloblastoma and its influencing factor analysis
原文传递
导出
摘要 目的探讨儿童髓母细胞瘤(MB)术后的生存情况及其影响因素。方法回顾性分析2011年1月至2017年6月新疆医科大学第一附属医院神经外科采用手术治疗且临床资料完整的57例MB患儿的临床资料,术后接受放、化疗的患儿分别有26、21例(其中20例为放疗联合化疗)。随访患儿术后的生存情况等。绘制Kaplan-Meier生存曲线行生存分析,采用log-rank检验分析影响患儿总体生存期的可能因素。结果57例患儿的中位随访时间为27(6~64)个月。至随访末期,20例(35.1%)患儿存活;Kaplan-Meier生存分析显示,1、3、5年的生存率分别为71.4%,40.2%,22.2%;57例患儿的中位生存时间为27.3个月;术后行、未行放疗者的中位生存期分别为41.0、15.0个月,术后行、未行化疗者的中位生存期分别为42.5、15.0个月,差异均有统计学意义(均P<0.01);20例放疗联合化疗患儿的中位生存期为61.4个月,与27例单独行放疗或化疗患儿的40.7个月比较,差异有统计学意义(P=0.009);而不同性别、年龄、民族、肿瘤切除程度、肿瘤是否转移、病理学类型的患者间生存期的差异均无统计学意义(均P>0.05)。结论新疆地区MB患儿术后的生存期较短,术后放疗、化疗是影响其术后生存期的重要影响因素。 Objective To investigate the survival of children medulloblastoma(MB)after operation and its influencing factors.Methods A retrospective analysis was conducted on the clinical data of 57 children with MB who underwent surgical treatment and had complete clinical data at the Department of Neurosurgery,the First Affiliated Hospital of Xinjiang Medical University from January 2011 to June 2017.Among them,26 and 21 children underwent postoperative radiotherapy and chemotherapy respectively,and 20 out of them underwent radiotherapy+chemotherapy.The postoperative survival,radiotherapy and chemotherapy of the children were followed up.The Kaplan-Meier survival curve was drawn for survival analysis,and the log-rank test was used to analyze the possible factors affecting the overall survival of children.Results The median follow-up time of the 57 children was 27(6-64)months.At the end of follow-up,20 children(35.1%)survived,and the 1-,3-,and 5-year survival rates were 71.4%,40.2%,and 22.2%respectively.The Kaplan-Meier survival curve showed that the median survival time of 57 children was 27.3 months.The median survival time of patients with and without radiotherapy after surgery were 41.0 and 15.0 months respectively;the median survival time of children with radiotherapy and chemotherapy after surgery was 42.5 and 15.0 months respectively,and the differences were statistically significant(both P<0.01).The median survival time of 20 children with radiotherapy and chemotherapy was 61.4 months,which was significantly different compared with that of 27 children with radiotherapy or chemotherapy alone(40.7 months)(P=0.009).However,there were no significant differences in survival time among patients varying in the gender,age,ethnicity,degree of tumor resection,tumor metastasis,or pathological type(all P>0.05).Conclusion The postoperative survival time of children with MB in Xinjiang is short,and postoperative radiotherapy and chemotherapy are important factors affecting.
作者 范国锋 刘文 马小虎 吉文玉 图柯拜 刘东 汪永新 Fan Guofeng;Liu Wen;Ma Xiaohu;Ji Wenyu;Tu Kebai;Liu Dong;Wang Yongxin(Department of Neurosurgery,the First Affiliated Hospital of Xinjiang Medical University,Urumqi 830014,China)
出处 《中华神经外科杂志》 CSCD 北大核心 2022年第3期285-289,共5页 Chinese Journal of Neurosurgery
基金 新疆维吾尔自治区自然科学基金(2022D01C257)。
关键词 儿童 髓母细胞瘤 神经外科手术 存活率分析 因素分析 统计学 Child Medulloblastoma Neurosurgical procedures Survival analysis Factor analysis,statistical
  • 相关文献

参考文献7

二级参考文献34

  • 1Jong Hyung Yoon,Kyung Duk Park,Hyoung Jin Kang,Hyery Kim,Ji Won Lee,Seung-Ki Kim,Kyu-Chang Wang,Sung-Hye Park,Il Han Kim,Hee Young Shin.Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea[J].World Journal of Pediatrics,2017,13(4):367-373. 被引量:2
  • 2Sirachainan N, Nuchprayoon I, Thanarattanakorn P, et al. Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy[J]. J Clin Neurosci, 2011, 18 (4): 515-519.
  • 3Rieken S, Gaiser T, Mohr A, et al. Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept[J]. MC Cancer, 2010, 3(10): 450-453.
  • 4Liu Y, Zhu Y, Gao L, et al. Radiation treatment for medulloblastoma: a review of 64 cases at a single institute[J]. Jpn J Clin Oncol, 2005, 35(3): 111-115.
  • 5Varan A. Risk-adapted chemotherapy in childhood medulloblastoma[J]. Expert Rev Anticancer Ther, 2011, 11(5): 771-780.
  • 6Packer RJ, Vezina G. Management of and prognosis with medulloblastoma: therapy at a crossroads[J]. Arch neurol, 2008, 65(11): 1419-1424.
  • 7Riffaud L, Saikali S, Leray E, et al. Survival and prognostic factors in a series of adults with medulloblastomas [J]. J Neurosurg, 2009, 111(3): 478-487.
  • 8Khalil EM. Treatment results of adults and children with medulloblastoma NCI, Cairo University experience[J]. J Egypt Natl Canc inst, 2008, 20(2): 175-186.
  • 9Ellison DW, Kocak M, Dalton J, et al. Definition of disease-risk stratification groups in childhood medulloblastoma using combined elinieal, pathologic, and molecular variables[J]. J Clin Oneol, 2011, 29(11): 1400-1407.
  • 10Dhall G. medulloblastoma[J]. J Child Neurol, 2009, 24(11): 1418-1430.

共引文献70

同被引文献30

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部